Health and Plant Protein Group Limited (ASX:HPP) is an Australian public company focused on pursuing value-add opportunities through acquisitions, equity investments, and strategic combinations in the food and emerging sectors. Founded in 1941 and headquartered in Brisbane, Australia, with operations previously centered in Milton, Queensland, the company historically operated in the consumer staples industry, manufacturing and marketing confectionery ginger and ginger-based products to industrial, food service, and retail customers worldwide; producing and processing macadamia nuts in Hawaii through subsidiaries HPP America, Inc. and MacFarms LLC for wholesale and retail distribution; and providing tourism-related sales of ginger products and leisure activities in Australia. Its ginger segment involved manufacturing in Australia and Fiji, while the macadamia segment targeted global markets under brands like Royal Hawaiian Orchards.
In recent years, the company divested its core operating assets, including the sale of its U.S. macadamia division on April 14, 2023, which represented its primary business prior to the transaction, and earlier sales of its ginger business and The Ginger Factory tourist attraction. These divestitures left HPP as a cash-rich shell pursuing strategic shifts, with receipt of withholding tax refunds from the U.S. asset sale on May 13, 2025. On August 28, 2025, HPP announced a binding bid implementation agreement to acquire 100% of Red Earth Energy Storage Ltd (REES), a leader in Australian battery manufacturing and energy market software, in a share exchange valuing the combined entity at A$40 million, with HPP providing a A$2.5 million loan to REES beforehand to support working capital and expansion amid the federal Cheaper Home Batteries Program; the deal includes plans for HPP delisting post-August 28, 2025, and relisting of the merged group by Q1 2026. Previously known as Buderim Ginger Limited until 2015 and Buderim Group Limited until December 2020, HPP operates from Sydney NSW as its current head office and maintains a board including Executive Chairman Albert Tse and Non-Executive Directors Hugh Robertson and Qi Chen. The company targets shareholder returns via buy-backs or capital returns alongside such accretive opportunities.